Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09TQY
|
|||
| Drug Name |
Dusigitumab
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65] | Phase 2 | [1] | |
| Company |
MedImmune Gaithersburg, MD
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Insulin-like growth factor-II (IGF2) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.